Skip to main content
Download PDF

MAML1: a coregulator that alters endometrial epithelial cell adhesive capacity

Fertility Research and Practice volume 7, Article number: 8 (2021) Cite this article

Abstract

Background

Abnormalities in endometrial receptivity has been identified as a major barrier to successful embryo implantation. Endometrial receptivity refers to the conformational and biochemical changes occurring in the endometrial epithelial layer which make it adhesive and receptive to blastocyst attachment. This takes place during the mid-secretory phase of woman’s menstrual cycle and is a result of a delicate interplay between numerous hormones, cytokines and other factors. Outside of this window, the endometrium is refractory to an implanting blastocyst. It has been shown that Notch ligands and receptors are dysregulated in the endometrium of infertile women. Mastermind Like Transcriptional Coactivator 1 (MAML1) is a known coactivator of the Notch signaling pathway. This study aimed to determine the role of MAML1 in regulating endometrial receptivity.

Methods

The expression and localization of MAML1 in the fertile human endometrium (non-receptive proliferative phase versus receptive mid-secretory phase) were determined by immunohistochemistry. Ishikawa cells were used as an endometrial epithelial model to investigate the functional consequences of MAML1 knockdown on endometrial adhesive capacity to HTR8/SVneo (trophoblast cell line) spheroids. After MAML1 knockdown in Ishikawa cells, the expression of endometrial receptivity markers and Notch dependent and independent pathway members were assessed by qPCR. Two-tailed unpaired or paired student’s t-test were used for statistical analysis with a significance threshold of P < 0.05.

Results

MAML1 was localized in the luminal epithelium, glandular epithelium and stroma of human endometrium and the increased expression identified in the mid-secretory phase was restricted only to the luminal epithelium (P < 0.05). Functional analysis using Ishikawa cells demonstrated that knockdown of MAML1 significantly reduced epithelial adhesive capacity (P < 0.01) to HTR8/SVneo (trophoblast cell line) spheroids compared to control. MAML1 knockdown significantly affected the expression of classical receptivity markers (SPP1, DPP4) and this response was not directly via hormone receptors. The expression level of Hippo pathway target Ankyrin repeat domain-containing protein 1 (ANKRD1) was also affected after MAML1 knockdown in Ishikawa cells.

Conclusion

Our data strongly suggest that MAML1 is involved in regulating the endometrial adhesive capacity and may facilitate embryo attachment, either directly or indirectly through the Notch signaling pathway.

Background

Implantation failure is a major contributor to infertility, contributing to more than 50% of the lost pregnancies [1, 2]. In order for successful implantation to occur, the endometrium must be receptive to a competent blastocyst [3]. Endometrial receptivity refers to the conformational and biochemical changes that take place in the functional layer of the endometrium to allow blastocyst attachment and invasion [4, 5]. It is known that endometrial tissue is only receptive to a competent blastocyst during the window of implantation which occurs during the mid-secretory phase (days 19–23 of a 28-day cycle) of the menstrual cycle and is otherwise refractory to blastocyst adhesion [4, 6]. Such cycle-dependent functional changes require delicate interplay between numerous hormones, cytokines and signaling pathways and are essential to secure a successful embryo attachment and implantation.

The Notch signaling pathway is one of the most highly conserved receptor-ligand signaling cascade families in multicellular organisms. It is involved in the regulation of cell proliferation, differentiation, invasion, adhesion and apoptosis via cell-cell interactions, thus directly impacting the fate of neighbouring cells [7, 8]. Notch receptors are plasma bound and have glycoprotein ligands. All four notch receptors and five ligands Jagged-1 and -2 and Delta-like (DLL)-1, − 3 and − 4 are known to be expressed by the endometrium [7, 9,10,11,12]. Notch pathway components are cyclically regulated in the endometrium [7] and Notch signaling plays an essential role in endometrial stromal cell decidualization and implantation [12,13,14]. Presence of Notch members in endometrial epithelium is of particular interest as it may suggest their role in facilitating the cell surface adhesive properties unique to a receptive endometrium and critical for successful implantation. In support of this hypothesis, conditional knockout of the Notch ligand JAG1 in mouse endothelial cells blocks endothelial-to-mesenchymal transition [15] which is a similar process compared to plasma membrane transformation that occurring in the endometrial luminal epithelium during receptive phase to facilitate embryo implantation [16]. Furthermore, it has been identified that Jagged1, Jagged2, DLL1 and Notch Receptor 1 (NOTCH1) expression are significantly lower at the mid-secretory phase in women with infertility, compared to fertile subjects [7, 17, 18]. However, the functional consequences of dysregulated Notch signaling on endometrial receptivity have not been clearly addressed.

Canonical Notch signaling is achieved when a Notch ligand on an adjacent cell membrane binds with a functional extracellular domain of the receptor on the target cell, resulting in release of the Notch intracellular domain (NICD). The NICD is then translocated to the nucleus where it can bind to a complex of proteins including recombining binding protein suppressor of hairless (RBPJ) and Mastermind Like Transcriptional Coactivator 1 (MAML1) to activate the transcription of Notch target genes [7, 8]. As one of the three co-regulators, MAML1 functions as a transcription coactivator for Notch pathway [19] thus directly regulating Notch signaling downstream activities. Studies have also shown that MAML1 expression levels in cells may act to alter Notch signaling, thus contributing to the diversity of functions resulting from Notch pathway [20, 21].

Apart from its well-known function in the Notch pathway, it has recently been identified that MAML1 also participates in the Hippo pathway. The Hippo signaling pathway is a highly conserved kinase cascade involved in the regulation of various biological processes including cell and tissue growth, cellular differentiation and regeneration [22]. Research has shown that members of the Hippo signaling pathway are expressed in the endometrium and are thought to play a role in decidualization and regulation of endometrial fibrosis [23, 24]. Activation of Hippo pathway phosphorylates either the mammalian transcriptional activator ‘Yes-associated protein’ (YAP), or its paralog with PDZ-binding motif (TAZ) which encourages cytoplasmic retention and prevents YAP/TAZ’s transport into the nucleus. When the hippo cascade is inactive, unphosphorylated YAP/TAZ can translocate into the nucleus to mediate gene transcription [22]. Most recently, a study has shown that MAML1/2 are involved in the retention of YAP/TAZ in the nucleus and promoting transcriptional activity [25]. This suggests that MAML1 may play an important role in the regulation of Hippo signaling and could be involved in the Hippo pathway in the endometrial epithelium and therefore involved in endometrial receptivity. MAML1 can regulate other signaling pathways including Sonic Hedgehog and NF-kB pathways [26]. It has been shown that NF-kB pathway can regulate Hippo signaling targets such as ANKRD1 in a Hippo signaling-independent manner [27], illustrating the complexity of downstream effects regulated by MAML1.

Loss of MAML1 in mice results in growth retardation, skeletal degeneration and postnatal lethality [28] so its endometrial function including uterine receptivity is unknown. To the best of our knowledge, there is presently no research exploring the function of MAML1 on endometrial receptivity. This study aimed to determine the role of MAML1 in regulating endometrial epithelial cell adhesive capacity and understand its mechanism of action through either Notch dependent or independent pathways.

Methods

Endometrial tissue collection

Following approval from the Human Research Ethics Committees at Monash Health (#03066B) and the Royal Women’s Hospital (SSA1813), functional layer endometrial tissue biopsies were collected from women (aged 26–42 years) who provided informed consent prior to undergoing surgical procedures for mirena insertion or benign ovarian cyst assessment. All women in this study were fertile with proven parity (≥1 parous pregnancy), regular menstrual cycles (28-32 days) and were not using intrauterine or hormonal contraceptives for at least 3 months before surgery. Tissue samples were collected by curettage and examined by gynecological pathologists at the Royal Women’s Hospital to confirm cycle stage. Proliferative phase (n = 4) and mid-secretory phase (n = 4) endometrium were used for this study.

Antibodies and cell lines

Rabbit polyclonal antibody against MAML1 (PA5111083) was purchased from Thermo (Waltham, MA, USA). HRP-GAPDH antibody was from Cell Signaling Technology (Danvers, MA, USA, #3683). IgG isotype control (Rabbit IgG fraction, #X0903) was from DAKO (Glostrup, Municipality, Denmark). Ishikawa and HTR8/SVNeo cells were used to investigate the adhesive capacity of the endometrium and blastocyst-endometrium interactions. The Ishikawa cell line was provided by Dr. M. Nishida (Tsukuba University, Tochigi, Japan). The Ishikawa cell line is derived from endometrial adenocarcinoma cells and represents a similar phenotype to endometrial luminal and glandular epithelial cells, not only in the expression of estrogen and progesterone receptors (ESR and PGR) but also in its cell-cell adhesive capacity [29, 30]. The HTR8/SVneo trophoblast cell line (CRL-3271) was purchased from the ATCC and cultured as in the manufacturer’s instructions.

MAML1 siRNA transfection

Ishikawa cells at 70–80% confluency were transfected with Lipofectamine RNAiMAX and Opti-MEM medium (Thermo) containing 20 nM MAML1 siRNA or scrambled control (Dharmacon, Lafayette, CO, USA) according to the manufacturer’s instructions. After 24 h the transfection medium was replaced with fresh culture medium and transfected Ishikawa cells were cultured for 48 h before being subjected to spheroid adhesion assay or other downstream analyses.

Immunohistochemistry

Human endometrial tissues were fixed in 10% formalin, embedded in paraffin and sectioned at 4 μm thickness. Slides were dewaxed, rehydrated and subjected to heat induced antigen retrieval (microwaving in 10 mM sodium citrate pH 6 for 6 min). Endogenous peroxidase activity was then blocked using 3% hydrogen peroxide diluted in methanol and incubated for 15 min at room temperature. After Tris-buffered saline (TBS) wash (twice for 5 min each), slides were incubated in a non-immune blocking buffer (10% goat serum and 2% human serum in TBS) for 30 min at room temperature. Immediately following this MAML1 antibody (1 μg/mL) and a normal rabbit immunoglobulin fraction (1 μg/mL) were added and incubated overnight at 4 °C. These slides were then washed with TBS-Tween 0.6% (v/v) and positive signaling was revealed via the avidin-biotin- diaminobenzidine system. Sections were counterstained with hematoxylin to indicate cell nuclei (blue). Slides were then mounted with DPX and imaged using an Olympus light microscope. Staining intensity scores were determined by two individual scorers blinded to the patient characteristic and averaged for statistical analysis, as previously described [31]. Briefly, a score of 0 denoted no positive MAML1 staining and 3 was intense staining. Each score was based on overall staining intensity of the whole endometrial section.

Spheroid adhesion assay

Passaged HTR8/SVneo cells were counted using Countess and 2000 cells/well were plated into wells of a U-shaped, ultra-low attachment 96 well plate (Sigma, CatCLS7007, St. Louis, MO, USA). Cells were then cultured for 48 h to form spheroids and 20 spheroids were collected and transferred to transfected Ishikawa cell monolayer (20 spheroids/well of 96 well plate) to initiate spheroid adhesion assay. The initial spheroid numbers per well were recorded using a light microscope before being allowed to co-incubate for 4 h at 37 °C. Afterward, all culture medium was removed and each well was gently washed once by adding 150 μL PBS to remove non-adherent spheroids. The remaining spheroids were then counted, and the percentage attachment was expressed as a percentage of the original spheroid number as previously reported [32, 33].

RNA isolation and RT-qPCR

RNA was retrieved from transfected Ishikawa cells. Cells were lysed with TRI Reagent (Sigma). RNA was isolated according to the manufacturer’s protocol and treated with RNase-free DNase set (Qiagen) to remove genomic DNA contamination. RNA concentration was determined by Nanodrop spectrophotometers (Thermo). After isolation, 300 ng total RNA was converted to cDNA using SuperScript™ III First-Strand Synthesis System (18080–051, Thermo). qPCR was performed on the Applied Biosystems ViiA7 system using SYBR Green Master Mix (4,367,659, Thermo) as previously described [34]. Primers used are summarized in Additional file 1. Gene expression was normalized to 18S. Relative expression levels were calculated using the comparative cycle threshold method (ΔΔCt).

Immunoblotting

Protein was extracted from the organic phase of TRI Reagent based RNA isolation as previously described [35]. Proteins were resolved by SDS-PAGE (150 V, 1 h) and transferred to polyvinylidene difluoride membranes (pre-soaked with methanol). Membranes were blocked with 5% skim milk in TBS for 1 h and incubated with MAML1 antibody (1:1000) prepared in 5% skim milk. Membranes were washed three times with TBS-Tween 0.1% (v/v) and incubated with horse radish peroxidase (HRP)-conjugated secondary antibody against rabbit and HRP-GAPDH (13,000, as a loading control). Labeled proteins were detected by chemiluminescence. For quantification, appropriate bands were assessed by densitometry, normalized against a loading control GAPDH, as previously described [36].

Statistics

Statistical analysis was performed using PRISM 8.0 and two-tailed paired or unpaired student’s t-test were used for statistical analysis with a significance threshold of P < 0.05. Data were presented as the mean ± SEM.

Results

MAML1 expression significantly increases in the luminal epithelium during the receptive mid-secretory phase compared to the non-receptive proliferative phase in fertile women

We first sought to determine the relevance of MAML1 on receptivity by assessing its expression and immunolocalization on proliferative phase and mid-secretory phase endometrium, which respectively represent non-receptive and receptive status of the endometrium for an implanting blastocyst. Immunohistochemistry staining illustrated a nuclear localization of MAML1 protein in the luminal epithelium, glandular epithelium and stroma of the endometrium of fertile women during the proliferative phase and mid-secretory phase (Fig. 1a). The intensity and frequency of MAML1 was scored by two blinded scorers independently on a scale of 0–3. Only luminal epithelium showed a significant increase (P < 0.05) of MAML1 staining in the mid-secretory phase when compared to the proliferative phase (Fig. 1b). No significant differences were recorded in either glandular epithelium or stroma between two phases (Fig. 1b). The specificity of MAML1 antibody labeling was confirmed through the inclusion of an IgG control in which MAML1 antibody was replaced with a normal rabbit immunoglobulin fraction (Fig. 1a).

Fig. 1
figure 1

Comparison of MAML1 expression in fertile proliferative phase and mid-secretory phase endometrium. a Immunohistochemistry detection of MAML1 in luminal epithelium (L) glandular epithelium (G) and stroma (S) of human endometrium. A nuclear labeling was recorded in all cell types. The specificity of MAML1 labeling was confirmed through the inclusion of an isotype control in which the non-immune antibody of the same isotype was substituted for the MAML1 antibody at the same concertation. Sections were counterstained with hemotoxylin to highlight the cell nuclei (blue). b Staining intensity of MAML1 was semi-quantitated by scoring staining in tissues blinded to cycle stage. Data were presented as mean ± SEM. (n = 4). *P < 0.05

Full size image

siRNA knockdown of MAML1 in Ishikawa cells impaired HTR8/SVneo spheroid adhesion

Ishikawa cells (endometrial adenocarcinoma cells) were used as a model to assess the functional consequences of MAML1 knockdown on epithelial cell adhesion. Ishikawa cells were transfected with 20 nM of scrambled control or MAML1 siRNA and subjected to spheroid adhesion assay to assess changes of adhesive capacities. qPCR analysis confirmed a successful knockdown of MAML1 in MAML1 siRNA treated group, compared to scrambled control (P < 0.0001, Fig. 2a). Such knockdown was further validated at the protein level by immunoblotting and densitometry analysis (P < 0.05, Fig. 2b). HTR8/SVneo spheroids added to cultured Ishikawa cell confluent monolayers in a spheroid adhesion assay showed the functional consequences of MAML1 knockdown on the adhesion of spheroids to the Ishikawa cells. Figure 2c and d demonstrated that HTR8/SVneo spheroid adhesion was significantly lower in siRNA MAML1 transfected Ishikawa cells compared to the scrambled control transfected Ishikawa cells (P < 0.01).

Fig. 2
figure 2

Examination of the effect of MAML1 knockdown on Ishikawa cell adhesive capacity. Ishikawa cells were transfected with either MAML1 siRNA (20 nM) or scrambled control (20 nM) before HTR8/SVneo spheroid adhesion assay or other analysis. a MAML1 knockdown was confirmed by qPCR. Expression levels were normalized to 18S (n = 9). b MAML1 knockdown was confirmed by immunoblotting and densitometry, normalized against a loading control GAPDH (n = 4). c MAML1 knockdown significantly compromised the spheroid adhesion compared to scrambled control (n = 5). d Representative images are presented to show attached spheroids on the Ishikawa cell monolayer after adhesion assay. Data were presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001

Full size image

The effect of MAML1 knockdown on notch dependent and independent pathway members

We next determined if knockdown of MAML1 in Ishikawa cells affected Notch pathway dependent activities. Hairy and enhancer of split (HES) 1, HES5 and Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) are most commonly used to investigate Notch pathway transcriptional activity [7, 37] and were therefore chosen for qPCR analysis. Expression levels of RBPJ, the MAML1 coactivator and Notch Regulated Ankyrin Repeat Protein (NRARP), downstream effector of Notch pathway were also examined. As shown in Fig. 3, when comparing MAML1 siRNA treated to scrambled control treated Ishikawa cells, HEY1 and NRARP expression were significantly decreased following MAML1 knockdown. The difference in expression levels of HES1 and HES5 in MAML1 siRNA treated cells compared to scrambled control treated cells, were not statistically significant. Similarly, RBPJ, a coactivator of MAML1 showed no significant difference in expression after MAML1 knockdown (Fig. 3).

Fig. 3
figure 3

Qualitative qPCR examination of the effect of MAML1 knockdown on common Notch pathway members. HEY1 and NRARP expression were significantly decreased after MAML1 knockdown in Ishikawa cells compared to scrambled control. Expression levels were normalized to 18S (n = 7). Data were presented as mean ± SEM. *P < 0.05, **P < 0.01, ns: no significant difference

Full size image

As MAML1 siRNA treatment compromised Ishikawa adhesive capacity, we next selected three endometrial receptivity markers namely SPP1, Dipeptidyl peptidase 4 (DPP4) and LIF [38] and examined their mRNA expressional changes after MAML1 knockdown. qPCR examination showed that the expression of SPP1 and DPP4 were significantly decreased (P < 0.05) while for LIF no significant difference was observed in MAML1 siRNA treated Ishikawa cells compared to scrambled control treated cells (Fig. 4a). We further confirmed that such changes were not mediated through the ESR and PGR as no significant changes were recorded of these two hormone receptors between control and MAML1 siRNA treated groups (Fig. 4b).

Fig. 4
figure 4

Effect of MAML1 knockdown on the expression of endometrial receptivity markers and hormone receptors. Expression levels were normalized to 18S (n = 7). Data were presented as mean ± SEM. *P < 0.05, ns: no significant difference

Full size image

The expression levels of Hippo transcriptional targets, ANKRD1 and Connective tissue growth factor (CTGF), and a downstream regulator, YAP1 were also examined after MAML1 siRNA treatment in Ishikawa cells. Most notably, ANKRD1 expression was significantly higher (P < 0.001) in MAML1 siRNA treated Ishikawa cells compared to control (Fig. 5). YAP1 expression increased as well, though not significant (P > 0.05), while CTGF expression remained largely unchanged between groups (Fig. 5).

Fig. 5
figure 5

Examination of the effect of MAML1 knockdown on the expression of Hippo pathway downstream effectors. Expression levels were normalized to 18S (n = 7). Data were presented as mean ± SEM. ***P < 0.001, ns: no significant difference

Full size image

Discussion

This study identifies a novel role for MAML1 in endometrial receptivity via its regulation of endometrial epithelial cell adhesive capacity. We demonstrated that MAML1 was upregulated in the endometrial luminal epithelium during the mid-secretory (receptive) phase of the menstrual cycle and that loss of MAML1 impaired trophoblast (HTR8/SVneo) spheroid attachment to an endometrial epithelial cell monolayer in vitro. Our data suggests MAML1 signaling may be required for endometrial epithelial expression of key regulators of endometrial receptivity including SPP1 and DPP4.

Overall, this study strongly supports a role for MAML1 in regulating endometrial receptivity. In fertile endometrium we found MAML1 production was significantly increased in the luminal epithelium during the receptive phase and using an in vitro model of blastocyst implantation [34] we demonstrated that endometrial epithelial MAML1 production was required for trophoblast spheroid adhesion. While this study only included a few clinical samples from the proliferative and mid-secretory phases to represent non-receptive and receptive status of the endometrium, it nevertheless supports the importance of MAML1 in regulating human endometrial receptivity. Further studies using larger samples sizes and in tissues from women with fertility and infertility/implantation failure are required to confirm our observations. Using qPCR we identified that MAML1 positively regulates Ishikawa cell production of known regulators of endometrial epithelial receptivity, DPP4 and SPP1 [39,40,41,42,43]. By meta-analyses, both SPP1 and DPP4 are elevated in the endometrium during the receptive phase [40, 44]. SPP1 and DPP4 are both membrane-bound extracellular glycoproteins which have established roles in cell adhesion. SPP1 is maximally produced by endometrial glands and found in uterine lavage during the mid-secretory phase [45, 46]. SPP1 is the only gene consistently up-regulated during the receptive phase in analyses of five studies [47], highlighting its likely importance in regulating receptivity. The role of SPP1 in regulating embryo adhesion has been well characterized in pigs, where SPP1 is secreted by the uterus just prior to embryo implantation and promotes embryo adhesion by interaction with integrins on the conceptus-maternal interface [48]. Like SPP1, DPP4 shows up-regulation during the receptive phase in both mRNA and immunohistochemical studies [47, 49, 50]. DPP4 is predominantly expressed by the uterine luminal and glandular epithelium [50] and is down-regulated in women with repeated implantation failure [49]. There has been no previous investigation of direct MAML1 regulation of either SPP1 or DPP4, however MAML1 is predicted to directly regulate transcription of both SPP1 and DPP4 by the presence of RBPJ binding sites in the promoter region of each gene and SPP1 is a direct target of Notch signaling [51, 52].

MAML1 has largely been described as a co-activator of the Notch pathway [53]. Here we found that MAML1 activity in Ishikawa cells was required for transcription of multiple Notch pathway factors including HEY1, NRARP and SPP1. HEY1 is regulated by MAML1 in melanoma [54] and human umbilical venous endothelial cells [55]. NRARP is a negative regulator of Notch signaling [56] and in Xenopus, the NRARP complex can include Mastermind [57]. SPP1 is a direct target of the Notch pathway in osteoblasts [51] and human hepatocellular carcinoma [52]. Interestingly, MAML1 loss had no effect on HES1 or HES5 expression in Ishikawa cells. It is possible that MAML3 is acting to compensate for loss of MAML1 in this study given their structural and functional similarity to MAML1: studies in mice suggest that Maml1/3 may perform redundant roles during embryogenesis with a duel knockout required to replicate pan-notch defects [20]. In mouse embryos loss of both Maml1 and Maml3 is required to alter transcription of Hey1 and Hes5 [20]. All together, these data support a direct role for MAML1 in the regulation of Notch signaling in Ishikawa cells although the functional effect of MAML2/3 in compensating for the loss of MAML1 requires further investigation.

Despite the Notch family first being identified as cell adhesion molecules in Drosophila and evidence demonstrating this function is conserved in mammals [58], there is a paucity of research investigating the mechanism by which the Notch signaling pathway mediates cell adhesion [58]. Notch signaling promotes the transcription and activation of cell adhesion molecules including integrins [58]. We have previously shown that Notch 1, DLL1 and Jagged1 are all significantly decreased in the endometrial epithelium of women with unexplained primary infertility [7, 18]. Interestingly, loss of endometrial epithelial DLL1 in women with unexplained primary infertility may be due to excess cleavage of DLL1 by ADAM17, increasing soluble (s)DLL1 in the uterine lumen [59]. sDLL1 is increased in the uterine lavage of women with primary infertility and impairs blastocyst adhesion in our in vitro model of blastocyst implantation [59]. It would be interesting to determine whether Notch pathway components sDLL1 or Jagged1, which are downregulated in unexplained primary infertility, alter MAML1 activity in endometrial epithelial cells – certainly a mutation in the DLL1 gene which is predicted to impair DLL1 binding to Notch receptors down-regulates MAML1 (and HEY1) in peripheral blood mononuclear cells [60].

MAML1 also has reported functions independent of the Notch pathway [61], including the Hippo [25], Sonic Hedgehog and NF-kB pathways [26]. We explored whether MAML1 regulated Hippo pathway components in Ishikawa cells. There is little information on the role of the Hippo pathway in the endometrium. The Hippo/YAP pathway is required for decidualization of endometrial stromal cells [23], likely associated with the Hippo pathway’s role in regulating cell proliferation to control organ size [25]. ANKRD1 and CTGF are commonly considered as Hippo pathway transcriptional gene targets. While CTGF expression remained unchanged, loss of MAML1 significantly increased ANKRD1 transcription here suggesting that MAML1 may act to turn the Hippo pathway ‘on’ in endometrial epithelial cells, which would inhibit transcription. However, this is inconsistent with previous research which demonstrated that MAML1 facilitates nuclear retention of YAP/TAZ (Hippo pathway ‘off’), and therefore, promotes transcription [25]. Moreover, DPP4 has been identified as a target of the Hippo/YAP pathway in cardiac fibroblasts [62] and was positively regulated by MAML1 in Ishikawa cells here. Possibly MAML1 is regulating ANKRD1 in a Hippo-independent manner – ANKRD1 transcription is repressed by sonic hedgehog treatment in mouse fibroblasts [63] and NF-kβ inhibition in human airway smooth muscle cells [27]. Altogether these studies suggest that the MAML1 may act independently of the Notch pathway in the endometrial epithelium, but further research is required to determine the precise role of MAML1 in endometrial receptivity.

Conclusions

In conclusion, our study has provided the first evidence that MAML1 may be a critical component in the regulation of endometrial epithelial cell adhesive capacity during endometrial receptivity and blastocyst implantation. Our study suggests that MAML1 may be acting as a co-activator of the Notch signaling pathway to directly or indirectly alter expression and, perhaps, function of endometrial receptivity markers. We also show that MAML1 may have non-canonical actions in the endometrial epithelium, including acting as a co-activator of Hippo signaling. Understanding the mechanism of action of MAML1 in the endometrium may uncover novel targets for therapies to treat female infertility and key pathways indicating the optimal time for embryo transfers to improve IVF success.

Availability of data and materials

All data generated through this study are included in this article.

Abbreviations

MAML1:

Mastermind Like Transcriptional Coactivator 1

ANKRD1:

Ankyrin repeat domain-containing protein 1

DLL:

Delta-like

NOTCH1:

Notch Receptor 1

NICD:

Notch intracellular domain

YAP:

Yes-associated protein 1

RBPJ:

Recombining binding protein suppressor of hairless

PGR:

Progesterone receptor

ESR:

Estrogen receptor

TBS:

tris-buffered saline

PBS:

phosphate-buffered saline

HEY1:

Hairy/enhancer-of-split related with YRPW motif protein 1

HES1:

Hairy and enhancer of split 1

HES5:

Hairy and enhancer of split 5

NRARP:

Notch Regulated Ankyrin Repeat Protein

SPP1:

Secreted Phosphoprotein 1

DPP4:

Dipeptidyl peptidase 4

LIF:

Leukemia Inhibitory Factor

CTGF:

Connective tissue growth factor

HRP:

Horse radish peroxidase

References

  1. Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens JJ, et al. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(2):202–23. https://doi.org/10.1093/humupd/dmy044.

    Article  CAS  PubMed  Google Scholar 

  2. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319(4):189–94. https://doi.org/10.1056/NEJM198807283190401.

    Article  CAS  PubMed  Google Scholar 

  3. Katzorke N, Vilella F, Ruiz M, Krüssel J-S, Simon C. Diagnosis of endometrial-factor infertility: current approaches and new avenues for research. Geburtshilfe Frauenheilkd. 2016;76(6):699–703. https://doi.org/10.1055/s-0042-103752.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lessey BA, Young SL. What exactly is endometrial receptivity? Fertil Steril. 2019;111(4):611–7. https://doi.org/10.1016/j.fertnstert.2019.02.009.

    Article  PubMed  Google Scholar 

  5. Evans J, Salamonsen LA, Winship A, Menkhorst E, Nie G, Gargett CE, et al. Fertile ground: human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016;12(11):654–67. https://doi.org/10.1038/nrendo.2016.116.

    Article  CAS  PubMed  Google Scholar 

  6. Ochoa-Bernal MA, Fazleabas AT. Physiologic events of embryo implantation and Decidualization in human and non-human primates. Int J Mol Sci. 2020;21(6):1973. https://doi.org/10.3390/ijms21061973.

    Article  CAS  PubMed Central  Google Scholar 

  7. Van Sinderen M, Cuman C, Gamage T, Rainczuk K, Osianlis T, Rombauts L, et al. Localisation of the notch family in the human endometrium of fertile and infertile women. J Mol Histol. 2014;45(6):697–706. https://doi.org/10.1007/s10735-014-9587-y.

    Article  CAS  PubMed  Google Scholar 

  8. Bray SJ. Notch signalling in context. Nat Rev Mol Cell Biol. 2016;17(11):722–35.

    Article  CAS  PubMed  Google Scholar 

  9. Cobellis L, Caprio F, Trabucco E, Mastrogiacomo A, Coppola G, Manente L, et al. The pattern of expression of notch protein members in normal and pathological endometrium. J Anat. 2008;213(4):464–72. https://doi.org/10.1111/j.1469-7580.2008.00963.x.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mikhailik A, Mazella J, Liang S, Tseng L. Notch ligand-dependent gene expression in human endometrial stromal cells. Biochem Biophys Res Commun. 2009;388(3):479–82. https://doi.org/10.1016/j.bbrc.2009.07.037.

    Article  CAS  PubMed  Google Scholar 

  11. Mazella J, Liang S, Tseng L. Expression of Delta-like protein 4 in the human endometrium. Endocrinology. 2008;149(1):15–9. https://doi.org/10.1210/en.2007-0477.

    Article  CAS  PubMed  Google Scholar 

  12. Cuman C, Menkhorst E, Winship A, Van Sinderen M, Osianlis T, Rombauts LJ, et al. Fetal-maternal communication: the role of notch signalling in embryo implantation. Reproduction. 2014;147(3):R75–86. https://doi.org/10.1530/REP-13-0474.

    Article  CAS  PubMed  Google Scholar 

  13. Su R-W, Strug MR, Joshi NR, Jeong J-W, Miele L, Lessey BA, et al. Decreased notch pathway signaling in the endometrium of women with endometriosis impairs decidualization. J Clin Endocrinol Metab. 2015;100(3):E433–42. https://doi.org/10.1210/jc.2014-3720.

    Article  CAS  PubMed  Google Scholar 

  14. Afshar Y, Jeong J-W, Roqueiro D, DeMayo F, Lydon J, Radtke F, et al. Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J. 2012;26(1):282–94. https://doi.org/10.1096/fj.11-184663.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hofmann JJ, Briot A, Enciso J, Zovein AC, Ren S, Zhang ZW, et al. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development. 2012;139(23):4449–60. https://doi.org/10.1242/dev.084871.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Whitby S, Zhou W, Dimitriadis E. Alterations in epithelial cell polarity during endometrial receptivity: a systematic review. Front Endocrinol. 2020;11:596324. https://doi.org/10.3389/fendo.2020.596324.

    Article  Google Scholar 

  17. Amjadi F, Salehi E, Zandieh Z, Rashidi M, Taleahmad S. Comparative evaluation of NOTCH signaling molecules in the endometrium of women with various gynecological diseases during the window of implantation. Iran J Basic Med Sci. 2019;22(4):426–31. https://doi.org/10.22038/ijbms.2019.32961.7874.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cuman C, Menkhorst E, Rombauts L, Holden S, Webster D, Bilandzic M, et al. Preimplantation human blastocysts release factors that differentially alter human endometrial epithelial cell adhesion and gene expression relative to IVF success. Hum Reprod. 2013;28(5):1161–71. https://doi.org/10.1093/humrep/det058.

    Article  CAS  PubMed  Google Scholar 

  19. Nam Y, Weng AP, Aster JC, Blacklow SC. Structural requirements for assembly of the CSL· intracellular Notch1· mastermind-like 1 transcriptional activation complex. J Biol Chem. 2003;278(23):21232–9. https://doi.org/10.1074/jbc.M301567200.

    Article  CAS  PubMed  Google Scholar 

  20. Oyama T, Harigaya K, Sasaki N, Okamura Y, Kokubo H, Saga Y, et al. Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for notch signaling in vivo. Development. 2011;138(23):5235–46. https://doi.org/10.1242/dev.062802.

    Article  CAS  PubMed  Google Scholar 

  21. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol. 2002;22(21):7688–700. https://doi.org/10.1128/MCB.22.21.7688-7700.2002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ma S, Meng Z, Chen R, Guan K-L. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88(1):577–604. https://doi.org/10.1146/annurev-biochem-013118-111829.

    Article  CAS  PubMed  Google Scholar 

  23. Chen H, Song Y, Yang S, Fu J, Feng X, Huang W. YAP mediates human decidualization of the uterine endometrial stromal cells. Placenta. 2017;53:30–5. https://doi.org/10.1016/j.placenta.2017.03.013.

    Article  CAS  PubMed  Google Scholar 

  24. Zhu H-Y, Ge T-X, Pan Y-B, Zhang S-Y. Advanced role of hippo signaling in endometrial fibrosis: implications for intrauterine adhesion. Chin Med J. 2017;130(22):2732–7. https://doi.org/10.4103/0366-6999.218013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kim J, Kwon H, Shin YK, Song G, Lee T, Kim Y, et al. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. Proc Natl Acad Sci U S A. 2020;117(24):13529–40. https://doi.org/10.1073/pnas.1917969117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jin B, Shen H, Lin S, Li J-L, Chen Z, Griffin JD, et al. The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-κB signaling and cell survival. J Biol Chem. 2010;285(19):14356–65. https://doi.org/10.1074/jbc.M109.078865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mohamed JS, Boriek AM. Loss of desmin triggers mechanosensitivity and up-regulation of Ankrd1 expression through Akt-NF-κB signaling pathway in smooth muscle cells. FASEB J. 2012;26(2):757–65. https://doi.org/10.1096/fj.10-160291.

    Article  CAS  PubMed  Google Scholar 

  28. Oyama T, Harigaya K, Muradil A, Hozumi K, Habu S, Oguro H, et al. Mastermind-1 is required for notch signal-dependent steps in lymphocyte development in vivo. Proc Natl Acad Sci U S A. 2007;104(23):9764–9. https://doi.org/10.1073/pnas.0700240104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Nishida M. The Ishikawa cells from birth to the present. Hum Cell. 2002;15(3):104–17. https://doi.org/10.1111/j.1749-0774.2002.tb00105.x.

    Article  PubMed  Google Scholar 

  30. Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA. Models for study of human embryo implantation: choice of cell lines? Biol Reprod. 2010;82(2):235–45. https://doi.org/10.1095/biolreprod.109.077800.

    Article  CAS  PubMed  Google Scholar 

  31. Griffiths M, Van Sinderen M, Rainczuk K, Dimitriadis E. miR-29c overexpression and COL4A1 downregulation in infertile human endometrium reduces endometrial epithelial cell adhesive capacity in vitro implying roles in receptivity. Sci Rep. 2019;9(1):8644. https://doi.org/10.1038/s41598-019-45155-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Takamura M, Zhou W, Rombauts L, Dimitriadis E. The long noncoding RNA PTENP1 regulates human endometrial epithelial adhesive capacity in vitro: implications in infertility. Biol Reprod. 2019;102(1):53–62.

    Article  Google Scholar 

  33. Ling CK, Santos LL, Zhou W, Dimitriadis E. Chloride intracellular channel 4 is dysregulated in endometrium of women with infertility and alters receptivity. Biochem Biophys Res Commun. 2020;531(4):490–6. https://doi.org/10.1016/j.bbrc.2020.07.046.

    Article  CAS  PubMed  Google Scholar 

  34. Zhou W, Santos L, Dimitriadis E. Characterization of the role for cadherin 6 in the regulation of human endometrial receptivity. Reprod Biol Endocrinol. 2020;18(1):1–10.

    Article  Google Scholar 

  35. Kopec AM, Rivera PD, Lacagnina MJ, Hanamsagar R, Bilbo SD. Optimized solubilization of TRIzol-precipitated protein permits Western blotting analysis to maximize data available from brain tissue. J Neurosci Methods. 2017;280:64–76. https://doi.org/10.1016/j.jneumeth.2017.02.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zhou W, Anderson AL, Turner AP, De Iuliis GN, McCluskey A, McLaughlin EA, et al. Characterization of a novel role for the dynamin mechanoenzymes in the regulation of human sperm acrosomal exocytosis. Mol Hum Reprod. 2017;23(10):657–73. https://doi.org/10.1093/molehr/gax044.

    Article  CAS  PubMed  Google Scholar 

  37. Borggrefe T, Oswald F. The notch signaling pathway: transcriptional regulation at notch target genes. Cell Mol Life Sci. 2009;66(10):1631–46. https://doi.org/10.1007/s00018-009-8668-7.

    Article  CAS  PubMed  Google Scholar 

  38. Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50–60. https://doi.org/10.1016/j.fertnstert.2010.04.063.

    Article  CAS  PubMed  Google Scholar 

  39. Shimomura Y, Ando H, Furugori K, Kajiyama H, Suzuki M, Iwase A, et al. Possible involvement of crosstalk cell-adhesion mechanism by endometrial CD26/dipeptidyl peptidase IV and embryonal fibronectin in human blastocyst implantation. Mol Hum Reprod. 2006;12(8):491–5. https://doi.org/10.1093/molehr/gal019.

    Article  CAS  PubMed  Google Scholar 

  40. Altmäe S, Koel M, Võsa U, Adler P, Suhorutšenko M, Laisk-Podar T, et al. Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers. Sci Rep. 2017;7(1):10077. https://doi.org/10.1038/s41598-017-10098-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Johnson GA, Burghardt RC, Bazer FW. Osteopontin: a leading candidate adhesion molecule for implantation in pigs and sheep. J Anim Sci Biotechnol. 2014;5(1):56. https://doi.org/10.1186/2049-1891-5-56.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lessey BA. Adhesion molecules and implantation. J Reprod Immunol. 2002;55(1):101–12. https://doi.org/10.1016/S0165-0378(01)00139-5.

    Article  CAS  PubMed  Google Scholar 

  43. Liu N, Zhou C, Chen Y, Zhao J. The involvement of osteopontin and β3 integrin in implantation and endometrial receptivity in an early mouse pregnancy model. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):171–6. https://doi.org/10.1016/j.ejogrb.2013.06.019.

    Article  CAS  PubMed  Google Scholar 

  44. Mirkin S, Arslan M, Churikov D, Corica A, Diaz JI, Williams S, et al. In search of candidate genes critically expressed in the human endometrium during the window of implantation. Hum Reprod. 2005;20(8):2104–17. https://doi.org/10.1093/humrep/dei051.

    Article  CAS  PubMed  Google Scholar 

  45. von Wolff M, Strowitzki T, Becker V, Zepf C, Tabibzadeh S, Thaler CJ. Endometrial osteopontin, a ligand of Β3-integrin, is maximally expressed around the time of the 'implantation window'. Fertil Steril. 2001;76(4):775–81. https://doi.org/10.1016/S0015-0282(01)02015-5.

    Article  Google Scholar 

  46. Apparao KBC, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, et al. Osteopontin and its receptor αvβ3 integrin are Coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab. 2001;86(10):4991–5000.

    CAS  PubMed  Google Scholar 

  47. Horcajadas J, Pellicer A, Simon C. Wide genomic analysis of human endometrial receptivity: new times, new opportunities. Hum Reprod Update. 2007;13(1):77–86. https://doi.org/10.1093/humupd/dml046.

    Article  CAS  PubMed  Google Scholar 

  48. Erikson DW, Burghardt RC, Bayless KJ, Johnson GA. Secreted phosphoprotein 1 (SPP1, osteopontin) binds to integrin alphavbeta6 on porcine trophectoderm cells and integrin alphavbeta3 on uterine luminal epithelial cells, and promotes trophectoderm cell adhesion and migration. Biol Reprod. 2009;81(5):814–25. https://doi.org/10.1095/biolreprod.109.078600.

    Article  CAS  PubMed  Google Scholar 

  49. Shi C, Han HJ, Fan LJ, Guan J, Zheng XB, Chen X, et al. Diverse endometrial mRNA signatures during the window of implantation in patients with repeated implantation failure. Hum Fertil (Camb). 2018;21(3):183–94.

    Article  CAS  Google Scholar 

  50. Imai K, Maeda M, Fjjiwara K, Kariya M, Takakura K, Kanzaki H, et al. Dipeptidyl peptidase IV as a differentiation marker of human endometrial glandular cells. Hum Reprod. 1992;7(9):1189–94. https://doi.org/10.1093/oxfordjournals.humrep.a137824.

    Article  CAS  PubMed  Google Scholar 

  51. Shen Q, Christakos S. The vitamin D receptor, Runx2, and the notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 2005;280(49):40589–98. https://doi.org/10.1074/jbc.M504166200.

    Article  CAS  PubMed  Google Scholar 

  52. Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S, et al. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 2012;143(6):1660–9 e1667.

    Article  CAS  PubMed  Google Scholar 

  53. Kitagawa M. Notch signalling in the nucleus: roles of mastermind-like (MAML) transcriptional coactivators. J Biochem. 2016;159(3):287–94.

    CAS  PubMed  Google Scholar 

  54. Kang S, Yang C, Luo R. Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells. Biochem Biophys Res Commun. 2008;372(4):629–33. https://doi.org/10.1016/j.bbrc.2008.05.079.

    Article  CAS  PubMed  Google Scholar 

  55. Wöltje K, Jabs M, Fischer A. Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not notch signaling in endothelial cells. PLoS One. 2015;10(3):e0120547. https://doi.org/10.1371/journal.pone.0120547.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Jarrett SM, Seegar TCM, Andrews M, Adelmant G, Marto JA, Aster JC, et al. Extension of the Notch intracellular domain ankyrin repeat stack by NRARP promotes feedback inhibition of Notch signaling. Sci Signal. 2019;12(606):eaay2369.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Lamar E, Deblandre G, Wettstein D, Gawantka V, Pollet N, Niehrs C, et al. Nrarp is a novel intracellular component of the notch signaling pathway. Genes Dev. 2001;15(15):1885–99. https://doi.org/10.1101/gad.908101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Murata A, Hayashi S: Notch-Mediated Cell Adhesion. Biology (Basel) 2016, 5(1).

  59. Van Sinderen M, Oyanedel J, Menkhorst E, Cuman C, Rainczuk K, Winship A, et al. Soluble Delta-like ligand 1 alters human endometrial epithelial cell adhesive capacity. Reprod Fertil Dev. 2017;29(4):694–702. https://doi.org/10.1071/RD15313.

    Article  CAS  PubMed  Google Scholar 

  60. Barhoumi T, Nashabat M, Alghanem B, Alhallaj A, Boudjelal M, Umair M, et al. Delta Like-1 gene mutation: a novel cause of congenital vertebral malformation. Front Genet. 2019;10:534. https://doi.org/10.3389/fgene.2019.00534.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. McElhinny AS, Li JL, Wu L. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene. 2008;27(38):5138–47. https://doi.org/10.1038/onc.2008.228.

    Article  CAS  PubMed  Google Scholar 

  62. Xiao Y, Hill MC, Zhang M, Martin TJ, Morikawa Y, Wang S, et al. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development. Dev Cell. 2018;45(2):153–69 e156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Lu Y, Li J, Cheng J, Lubahn DB. Genes targeted by the hedgehog-signaling pathway can be regulated by estrogen related receptor β. BMC Mol Biol. 2015;16(1):19. https://doi.org/10.1186/s12867-015-0047-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Ms. Emily-jane Bromley for orchestrating the tissue collection and the women who donated the endometrial tissue used in this study.

Funding

This work was supported by a project grant and a senior research fellowship from the National Health and Medical Research Council (NHMRC) of Australia to E.D. W.Z. was supported by a Department Innovation Grant (University of Melbourne). E.M. was supported by a Department of Obstetrics and Gynaecology Mid-Career Research Fellowship (University of Melbourne). The authors have no competing interests to declare.

Author information

Author notes

  1. Sadaf Zafir and Wei Zhou contributed equally to this work.

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, 3010, Australia

    Sadaf Zafir, Wei Zhou, Ellen Menkhorst, Leilani Santos & Evdokia Dimitriadis

  2. Gynaecology Research Centre, Royal Women’s Hospital, Level 7, The Royal Women’s Hospital, 20 Flemington Road, Parkville, Victoria, 3052, Australia

    Sadaf Zafir, Wei Zhou, Ellen Menkhorst, Leilani Santos & Evdokia Dimitriadis

Authors
  1. Sadaf Zafir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ellen Menkhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leilani Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Evdokia Dimitriadis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.Z. and W.Z. conducted the experiments. W.Z. and E.M. generated the manuscript. L.S. scored MAML1 staining and reviewed the manuscript. E.D. conceived and designed the study, contributed to data interpretation and analysis, and manuscript preparation and review. All authors approved the final version and submission of this article.

Corresponding author

Correspondence to Evdokia Dimitriadis.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained from each patient and the study was approved by the Human Research Ethics Committee at Monash Health (#03066B) and the Royal Women’s Hospital (ID: SSA1813).

Consent for publication

Not applicable.

Competing interests

The authors report no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Primers used throughout this study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zafir, S., Zhou, W., Menkhorst, E. et al. MAML1: a coregulator that alters endometrial epithelial cell adhesive capacity. Fertil Res and Pract 7, 8 (2021). https://doi.org/10.1186/s40738-021-00100-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40738-021-00100-y

Keywords

  • Endometrial adhesion
  • Embryo implantation
  • Notch pathway
  • MAML1
  • Endometrial epithelial cell
  • Trophoblast cell
  • Hippo pathway

Fertility Research and Practice

ISSN: 2054-7099

Contact us